Department of Clinical Research, LifeScan, Inc., Milpitas, California 95035-6312, USA.
Diabetes Technol Ther. 2009 Oct;11(10):669-74. doi: 10.1089/dia.2009.0023.
Patients undergoing intensive insulin therapy may have blood glucose (BG) samples drawn from arterial, capillary, or venous sources. This study compared capillary and venous BG across a range of glucose concentrations and under conditions of rapid change in BG.
Following a 10-h fast, 40 adult patients with type 1 or 2 diabetes were connected to an automated glucose clamp device (Biostator, Miles Laboratories, Inc., Elkhart, IN) that induced a series of BG plateaus (hypoglycemic, euglycemic, hyperglycemic) and dynamic-state transitions (increasing, decreasing). Venous and capillary BG measurements were performed at different test points. Venous readings were adjusted to compensate for small time delays in obtaining the two samples.
Adjusted venous and capillary BG measurements were strongly correlated (R = 0.84; P < 0.0001). The bias between BG sources showed a weak but significant correlation with rate of BG change in the hypoglycemic range (P = 0.0282) but not in euglycemic or hyperglycemic BG ranges. The bias observed during dynamic conditions was two to three times larger than that observed during steady states. During rapid increases and decreases in BG (>2 mg/dL/min), 91.1% and 84.1% of paired capillary and venous results (n = 125), respectively, fell into Zone A of the consensus error grid versus 97.5% at slower rates.
Capillary and venous BG values are similar under steady-state conditions but may differ under dynamic conditions. Variability associated with these differences was substantial during all states. As hospital insulin infusion protocols are widely implemented, healthcare providers need to be aware that glucose values may differ when blood is sampled from capillary and venous sites. Based on the tight ranges used in these protocols, these differences may impact insulin dosing decisions.
接受强化胰岛素治疗的患者可能会从动脉、毛细血管或静脉采集血糖(BG)样本。本研究比较了在一系列血糖浓度下和血糖快速变化条件下毛细血管和静脉 BG。
在禁食 10 小时后,将 40 名 1 型或 2 型糖尿病成年患者连接到自动血糖钳设备(Biostator,Miles Laboratories,Inc.,Elkhart,IN),该设备诱导一系列 BG 平台(低血糖、正常血糖、高血糖)和动态状态转换(增加、减少)。在不同的测试点进行静脉和毛细血管 BG 测量。静脉读数进行了调整,以补偿获得两个样本之间的小时间延迟。
调整后的静脉和毛细血管 BG 测量值具有很强的相关性(R = 0.84;P <0.0001)。BG 源之间的偏差与低血糖范围内 BG 变化率呈弱但显著相关(P = 0.0282),但与正常血糖和高血糖范围内的 BG 变化率无关。在动态条件下观察到的偏差是在稳态条件下观察到的偏差的两到三倍。在 BG 快速增加和减少(>2mg/dL/min)期间,分别有 91.1%和 84.1%的毛细血管和静脉配对结果(n = 125)落入共识误差网格的 A 区,而较慢速率下为 97.5%。
在稳态条件下,毛细血管和静脉 BG 值相似,但在动态条件下可能不同。在所有状态下,这些差异相关的变异性都很大。随着医院胰岛素输注方案的广泛实施,医疗保健提供者需要意识到,从毛细血管和静脉部位采集血液时,血糖值可能会有所不同。基于这些方案中使用的严格范围,这些差异可能会影响胰岛素给药决策。